AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 20th, 2004 • Pressure Biosciences Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledSeptember 20th, 2004 Company Industry JurisdictionThis Amendment No. 1 to Asset Purchase Agreement (this "Amendment") is entered into effective as of July 20, 2004, by and among Boston Biomedica, Inc., a Massachusetts corporation ("Parent") and BBI Biotech Research Laboratories, Inc., a Massachusetts corporation ("BBI Biotech", and together with Parent, the "Seller"), and SeraCare Life Sciences, Inc., a California corporation ("Buyer").
EXTENSION AGREEMENTExtension Agreement • September 20th, 2004 • Pressure Biosciences Inc • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 20th, 2004 Company IndustryReference is made to that certain Amendment No. 1 to Asset Purchase Agreement (the "Amendment") dated July 20, 2004, by and among Boston Biomedica, Inc., BBI Biotech Research Laboratories, Inc. and SeraCare Life Sciences, Inc.